Reversible Covalent Ligand Design Services

* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.

Some of the most interesting targets in a degradation pipeline carry a nucleophilic residue in exactly the place a ligand needs to bind—but permanent modification of that residue is not always the right answer. A reversible covalent warhead forms a true covalent bond that can also break, combining the high target occupancy of covalent chemistry with the recoverability of noncovalent binding. For degrader programs, that combination supports repeated binding-and-release cycles rather than a single-turnover attachment.

BOC Sciences provides reversible covalent warhead design services for targeted protein degradation, covering nucleophile and binding-site feasibility assessment, chemotype selection, covalent ligand discovery, reversibility validation, kinetic characterization, and structure-guided warhead optimization. We integrate computational modeling, covalent screening, biophysical and mass-spectrometric analysis, and medicinal chemistry to deliver warheads whose covalent engagement is both productive and controllable.

Request a Consultation Explore Services
Overview

What Is a Reversible Covalent Warhead in Targeted Protein Degradation?

A reversible covalent warhead is a target-binding ligand that combines a recognition scaffold with a moderately reactive electrophile, forming a covalent bond to a nucleophilic amino acid residue—most often cysteine, and in suitable contexts lysine, serine, or threonine—that exists in equilibrium with the unbound state. Unlike an irreversible electrophile, the adduct slowly releases the parent ligand, so target occupancy is governed by both the association rate and the lifetime of the covalent adduct. This gives medicinal chemists an additional design dimension: residence time can be tuned deliberately, from minutes to days, by adjusting warhead electronics, sterics, and adduct stability rather than by simply increasing intrinsic reactivity.

In degradation research, this reversibility matters. Because the degrader is not consumed by a permanent attachment, a reversible covalent warhead can in principle support catalytic target turnover after the target is ubiquitinated and removed, while the covalent component still contributes sustained engagement, improved target occupancy, and a selectivity profile driven by recognition rather than raw electrophile reactivity.

Services

BOC Sciences Reversible Covalent Warhead Design Services for PROTAC Development

BOC Sciences delivers reversible covalent warhead design as an integrated workflow, from judging whether a target residue can support reversible covalent engagement to delivering optimized warheads with defined kinetic behavior. Our broader target protein ligand discovery and screening capabilities provide the foundation, and every covalent project is planned around the reversibility and residence-time profile the final degrader will need.

Gene Therapy

Target Nucleophile and Binding-Site Feasibility Assessment

We help determine whether reversible covalent engagement is realistic for your target, through:

  • Nucleophile assessment service: structure- and model-based evaluation of candidate cysteine, lysine, serine, or threonine residues, covering solvent exposure, local pKa, and reactive microenvironment analysis.
  • Binding-site ligandability service: characterization of the region surrounding the target residue to confirm it can host a recognition scaffold, built on our binding pocket analysis for TPD development.
  • Feasibility recommendation service: a written go/no-go assessment identifying the best residue-chemotype pairing, competing residues, and design risks before any chemistry is committed.
Gene Therapy

Reversible Covalent Ligand Discovery and Screening

BOC Sciences identifies warhead starting points for validated residues and binding regions through:

  • Covalent library screening service: chemotype-matched reversible covalent libraries screened with mass-spectrometry-based adduct detection.
  • Structure-based screening service: docking and virtual screening of candidate electrophiles against the target recognition region.
  • Known-ligand conversion service: installation of a reversible covalent group onto established target binders through our known ligand-derived warhead discovery services.
  • Hit triage service: ranking of hits on adduct formation, adduct lifetime, and scaffold recognition together, so early chemistry is aligned with the reversibility profile your program requires.
Gene Therapy

Reversibility Validation and Covalent Kinetic Characterization

We confirm the reversible nature of target engagement and quantify its kinetic signature before any optimization decision, using:

  • Reversibility validation service: dilution and washout experiments, intact-protein mass spectrometry, and NMR-based adduct exchange studies to confirm reversible target engagement.
  • Kinetic profiling service: measurement of adduct formation extent, association and dissociation behavior, and residence time under matched in vitro conditions.
  • Chemotype comparison service: head-to-head evaluation of candidate chemotypes to define the reversibility window best suited to your degrader architecture.
Gene Therapy

Warhead Optimization and Linker-Attachment Site Selection

BOC Sciences prepares a reversible covalent hit for conjugation through:

  • SAR optimization service: medicinal chemistry tuning of electrophile electronics, sterics, and β-substitution to shape association rate and adduct lifetime as separate design variables.
  • Exit-vector assessment service: identification of solvent-exposed attachment points that preserve the covalent geometry required for target engagement.
  • Linker compatibility service: evaluation of how linker attachment affects the covalent equilibrium, supported by our linker design and optimization services.
Warhead Types

Reversible Covalent Warhead Chemotypes We Design

BOC Sciences evaluates multiple chemotype families to identify an appropriate chemical strategy for each target rather than applying a single reactive group across different protein systems. Our warhead library can also provide a starting point for exploring relevant warhead structures and chemical building blocks.

Cysteine-Targeting Reversible Covalent Warheads

Cysteine is a widely explored nucleophilic residue in reversible covalent ligand design because its thiol group can participate in reactions with suitable electrophilic groups. BOC Sciences considers several cysteine-reactive chemotypes, including:

  • α-Cyanoacrylamides: These warheads can undergo reversible conjugate addition with cysteine thiols. Their substituents and surrounding scaffold influence electrophilic reactivity, adduct stability, and residence time.
  • Nitriles: Suitable nitrile groups can form reversible thioimidate adducts with cysteine residues. Their performance depends on electrophile activation, binding orientation, and the chemical environment of the target site.
  • Aldehydes: Aldehyde groups can form reversible hemithioacetal adducts with cysteine. Their reactivity and chemical stability require careful evaluation during ligand design.
  • Other Cysteine-Directed Motifs: Selected α-cyanocarbonyl and related electrophilic structures can provide additional options when their reaction geometry and reversibility are compatible with the target.

Lysine-Targeting Reversible Covalent Warheads

Lysine provides an alternative nucleophilic site for reversible covalent ligand design through its side-chain amino group. However, the protonation state and local environment of lysine can strongly influence its nucleophilicity. BOC Sciences evaluates the accessibility and chemical environment of potential lysine residues before selecting a suitable electrophilic group.

Representative design strategies include:

  • Aldehyde-Based Imine Formation: Aldehydes can react with lysine amino groups to form reversible imine or Schiff-base adducts. Neighboring residues and hydrogen-bond interactions may influence adduct stability.
  • Iminoboronate Formation: Boronic acid-containing motifs, particularly appropriately positioned formylboronic acid structures, can interact with amino groups to generate reversible iminoboronate complexes. Their formation depends on the local chemical environment and molecular geometry.

Serine/Threonine-Targeting Reversible Covalent Warheads

Serine and threonine contain hydroxyl groups that can participate in reversible covalent reactions when positioned within a suitable chemical environment. These residues provide additional design opportunities, particularly for proteins in which cysteine-based approaches are not feasible or do not offer the desired selectivity.

  • Boronic Acid Warheads: Boronic acids can form reversible boronate complexes with suitably positioned serine or threonine hydroxyl groups. Their binding behavior is influenced by boron coordination, local hydrogen bonding, and the geometry of the target site.
  • α-Oxoamides and α-Ketoamides: These carbonyl-containing motifs can undergo reversible nucleophilic addition in appropriately organized active sites. Their suitability for serine- or threonine-directed engagement depends on the local catalytic environment and the orientation of the carbonyl group.

Tunable-Reactivity and Extended-Reversibility Warheads

Some reversible covalent warheads provide opportunities to adjust electrophilic reactivity and covalent adduct dissociation through structural modification. This is important when a candidate forms an adduct too slowly, dissociates too rapidly, or maintains target engagement for longer than desired. BOC Sciences considers several tunable chemical motifs, including:

  • β-Substituted Cyanoacrylamides: Changes at the β-position can influence steric accessibility and adduct dissociation, providing a way to adjust the residence-time profile while retaining reversible cysteine engagement.
  • α-Cyanocarbonyls: These structures offer alternative electrophilic environments for reversible covalent interactions. Substituent changes can be explored to adjust reaction behavior and target compatibility.
  • Thiomethyltetrazines: These emerging reversible covalent motifs provide additional options for cysteine-directed ligand design and can be evaluated when their reaction mechanism is compatible with the target environment.

Which Reversible Covalent Warhead Is Suitable for Your Target?

Share your target protein, potential nucleophilic residues, and available structural information with BOC Sciences. Our team can evaluate cysteine-, lysine-, serine-, and threonine-directed chemotypes, compare their reaction mechanisms, and help identify a suitable starting strategy for your degrader project.

Discuss Your Warhead Strategy

Workflow

Our Workflow for Reversible Covalent Warhead Design

01

Project Review and Chemotype Strategy Selection

We review the target, its structures, candidate nucleophiles, and the degradation question you are pursuing, then recommend a residue-chemotype pairing together with the residence-time window the final degrader should aim for.

02

Covalent Ligand Discovery and Reversibility-Aware Screening

Discovery runs across chemotype-matched libraries and covalent fragment sets with mass-spectrometric adduct detection. Every hit is scored not only on labeling extent but on whether the adduct dissociates in the desired range.

03

Equilibrium and Kinetic Characterization of Covalent Engagement

Confirmed hits are profiled for adduct formation, dissociation kinetics, and residence time under matched conditions, with structural evidence showing the ligand bound in the intended pose relative to the target residue.

04

Structure-Guided Optimization and PROTAC Compatibility Assessment

Optimized warheads are delivered with exit-vector options and an assessment of how linker attachment affects the covalent equilibrium, then move into PROTAC design services for linker assembly and E3 ligand pairing.

Applications

Research Examples and Emerging Applications of Reversible Covalent Degraders

BTK-Driven B-Cell Malignancies, Including Chronic Lymphocytic Leukemia (CLL)

BTK is an important target in B-cell malignancy research because its Cys481 residue supports covalent ligand recognition. Reversible covalent PROTACs have demonstrated BTK degradation in primary CLL cells. An α-cyanoacrylamide-based candidate also showed improved target selectivity over non-covalent and irreversible covalent comparators, supporting further investigation of this strategy (J. Am. Chem. Soc., 2020).

FLT3-Mutant Acute Myeloid Leukemia (AML) Research

FLT3-ITD is an important driver of AML, and conventional FLT3 degraders have demonstrated mutant-protein removal and suppression of AML cell growth. This makes FLT3 an interesting target for exploring reversible covalent degradation, particularly when a suitable nucleophilic residue and binding geometry can be identified. Direct evidence for reversible covalent FLT3 degraders remains limited, making this a potential direction for further warhead design research (Eur. J. Med. Chem., 2024).

KRAS G12C-Driven Lung Cancer Research

KRAS G12C provides a direct proof of concept for reversible covalent degradation. YF135, a reversible covalent PROTAC, recruited VHL and induced endogenous KRAS G12C degradation in H358 and H23 lung cancer cells, accompanied by reduced pERK signaling. The mutant cysteine provides a defined recognition site for investigating selective oncogenic protein degradation (Eur. J. Med. Chem., 2022).

EGFR-Mutant and HER2-Driven Solid Tumor Research

EGFR-mutant and HER2-driven solid tumors represent another emerging application. A 2026 cyanobenzothiazole-based reversible covalent warhead platform engaged DCAF16 at Cys58 and demonstrated degradation of EGFR L858R/T790M/C797S and HER2. This approach illustrates how reversible covalent chemistry can facilitate E3 ligase recruitment and expand degrader design beyond strategies that rely exclusively on direct target-binding warheads (J. Med. Chem., 2026).

Do You Have an Application for Reversible Covalent Degrader Development?

Whether you are exploring established degradation targets or investigating new disease-associated proteins, BOC Sciences can help translate your research objectives into a feasible degrader strategy. Our team can support reversible covalent warhead design, degrader synthesis, and experimental evaluation to advance your project.

Discuss Your Project

Troubleshooting

Design Challenges We Solve in Reversible Covalent Warhead Programs

Reversible covalent warhead development requires precise control over target recognition, covalent reactivity, and adduct dissociation. BOC Sciences addresses these challenges through structural analysis, kinetic characterization, and structure-guided optimization.

Limited Accessibility and Insufficient Reactivity of Target Residues

A potential nucleophilic residue may be buried, transiently exposed, or insufficiently reactive, making covalent engagement difficult despite favorable static structures. BOC Sciences uses structural analysis and molecular dynamics simulation to evaluate residue accessibility across conformational states, then matches the local chemical environment to suitable warhead chemotypes or considers alternative target residues.

Difficulty Balancing Covalent Binding Strength and Adduct Reversibility

Excessive electrophilicity can produce overly persistent adducts, whereas insufficient reactivity may result in weak target occupancy. BOC Sciences evaluates adduct formation and dissociation kinetics, then optimizes warhead electronics, steric effects, and substituents to achieve a suitable residence-time profile without relying on binding affinity alone.

Unwanted Off-Target Covalent Reactions and Poor Target Selectivity

Highly reactive warheads may modify competing cellular nucleophiles, while insufficient target recognition reduces binding-site selectivity. BOC Sciences prioritizes non-covalent scaffold recognition, controls electrophile reactivity, and compares target engagement with competing thiols or related proteins to guide selective warhead optimization.

Loss of Target Engagement and Unproductive Ternary Complex Formation

Linker attachment may alter warhead orientation or obstruct the reactive residue, while unfavorable E3 ligase positioning can prevent productive ternary complex formation. BOC Sciences evaluates covalent engagement after conjugation, linker exit vectors, and ternary complex geometry, then optimizes attachment positions or explores alternative binding sites.

Facing Challenges in Reversible Covalent PROTAC Development?

Whether you are struggling with target residue selection, covalent reaction reversibility, off-target reactivity, or unproductive ternary complex formation, BOC Sciences can help identify and address your development challenges.

Discuss Your Challenges

Why Us

Why Choose BOC Sciences for Reversible Covalent Warhead Design?

Integrated Computational Modeling and Experimental Validation

Residue assessment, covalent docking, adduct-exchange prediction, and their experimental confirmation run inside one team, so a chemotype recommendation and its kinetic verification are never separated by a handoff.

Multi-Chemotype Reversible Covalent Warhead Design Capabilities

We design across cysteine, lysine, and serine/threonine chemotype families in parallel, so the electrophile is chosen by the residue and the required residence time, not by the platform we happen to have.

Kinetics- and Selectivity-Guided Warhead Optimization

Every optimization cycle tracks association rate, adduct lifetime, and off-target reactivity alongside occupancy, so the warhead you receive carries a defined kinetic profile rather than a single affinity value.

PROTAC-Oriented Warhead Design and Degradation Evaluation

Warheads are optimized with exit vectors, covalent-geometry retention, and ternary-complex feasibility in mind, and can be evaluated by degradation assays from the same compound batch, closing the loop between covalent design and degradation outcome.

Frequently Asked Questions (FAQ)

Frequently Asked Questions

Still have questions?

Contact Us

A reversible covalent warhead is worth considering when a target protein contains an accessible nucleophilic residue and conventional non-covalent ligands do not provide the desired target engagement or residence time. This approach may be particularly useful when a ligand can establish selective non-covalent recognition while positioning an electrophilic group near the intended residue. However, the presence of a reactive residue alone is insufficient. Its accessibility, local chemical environment, adduct formation and dissociation rates, and potential off-target reactions must also be evaluated. BOC Sciences can assess target-site feasibility, compare suitable warhead chemotypes, and investigate whether reversible covalent engagement offers a practical advantage for the intended PROTAC development program.

An irreversible warhead forms a covalent modification that is not expected to dissociate on the relevant experimental timescale, whereas a reversible warhead forms an adduct in equilibrium with the unbound target and ligand. Reversibility may allow the degrader to dissociate after target ubiquitination and potentially engage additional target molecules, supporting catalytic degradation. However, this recycling is not guaranteed and depends on the reverse reaction rate, target engagement, ternary complex lifetime, and cellular exposure. A published BTK study compared reversible, irreversible, and non-covalent PROTACs, demonstrating that their degradation mechanisms can differ.

Cysteine is the most established residue because its thiol group can be sufficiently nucleophilic in suitable binding environments. Other possibilities include lysine or N-terminal amino groups, as well as serine and threonine when the local catalytic environment activates their hydroxyl groups. Warhead selection must match the residue and its chemical environment. For example, cyanoacrylamides and selected nitriles are used for cysteine engagement, boronic acid motifs can engage serine hydroxyl groups, and iminoboronate chemistry can target amino groups. Residue accessibility, protonation, orientation, and competing nucleophiles all influence feasibility.

Reversibility should be demonstrated by combining direct adduct detection with experiments that investigate dissociation. Intact-protein mass spectrometry can reveal time-dependent adduct formation, while peptide-level mapping can help identify the modified residue. Dilution or washout experiments can test whether the adduct dissociates, and time-course binding measurements can help characterize association and reverse reaction behavior. These results should be interpreted alongside non-covalent affinity and target engagement. BOC Sciences can select an appropriate combination of analytical and biochemical methods based on the target, ligand chemistry, available protein materials, and specific research objectives.

A suitable PROTAC warhead must do more than form a reversible adduct. It needs a recognition scaffold that binds the target, an electrophile positioned to react with the intended residue, and kinetic behavior compatible with productive target engagement. After linker attachment, the ligand should retain its binding pose and provide an accessible exit vector for E3 ligase recruitment. Ternary complex formation and degradation must then be evaluated because strong binary binding does not guarantee productive ubiquitination or protein reduction. BOC Sciences supports target residue assessment, ligand discovery, kinetic characterization, linker attachment site optimization, and degrader evaluation.

* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.

  • Verification code
Inquiry Basket